Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients

驱动蛋白相关蛋白 3 (KIFAP3) 对 ALS 患者群体的生存没有影响

阅读:4
作者:Bryan J Traynor, Michael Nalls, Shiao-Lin Lai, Raphael J Gibbs, Jennifer C Schymick, Sampath Arepalli, Dena Hernandez, Marcel P van der Brug, Janel O Johnson, Allissa Dillman, Mark Cookson, Cristina Moglia, Andrea Calvo, Gabriella Restagno, Gabriele Mora, Adriano Chiò

Abstract

It was recently reported that rs1541160 on chromosome 1q24.2 has a marked effect on survival of amyotrophic lateral sclerosis (ALS) patients by influencing KIFAP3 expression. The cohorts used in that study were collected from ALS specialty clinics. We attempted to replicate these findings in a population-based cohort of 504 Italian ALS patients. None of 140 SNPs genotyped within the KIFAP3 locus (including rs1541160) had an effect on survival (log-rank P value for rs1541160 = 0.47) or on gene expression in that region. These data illustrate the complexities associated with analyzing ALS phenotypes for association.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。